Pancreatic Cancer Research

ResearcherThe University of Texas Southwestern Medical CenterNo recent work listed

Yuqing Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0740-5310; OpenAlex author ID A5051361960. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2019: 2 papers · 2020: none · 2021: none · 2022: 1 paper

Papers 3

  1. AXL Inhibitor TP-0903 Reduces Metastasis and Therapy Resistance in Pancreatic Cancer. Co-author DOI 10.1158/1535-7163.mct-21-0293↗
  2. Cyclooxygenase-2 Inhibition Potentiates the Efficacy of Vascular Endothelial Growth Factor Blockade and Promotes an Immune Stimulatory Microenvironment in Prec… Co-author DOI 10.1158/1541-7786.mcr-18-0427↗
  3. Targeting TGFβR2-mutant tumors exposes vulnerabilities to stromal TGFβ blockade in pancreatic cancer. First author DOI 10.15252/emmm.201910515↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huocong Huang · 3 shared papers, 2019–2022 · strength 0.35
  2. Rolf A. Brekken · 3 shared papers, 2019–2022 · strength 0.35
  3. Noah B. Sorrelle · 2 shared papers, 2019 · strength 0.19
  4. Francis J. Burrows · 1 shared paper, 2019 · strength 0.11
  5. Amanda Kirane · 1 shared paper, 2019 · strength 0.11
  6. Moriah M. Hagopian · 1 shared paper, 2019 · strength 0.08
  7. Wenting Du · 1 shared paper, 2019 · strength 0.08
  8. Mohamed Zaid · 1 shared paper, 2019 · strength 0.08
  9. Abdel Nasser Hosein · 1 shared paper, 2019 · strength 0.08
  10. Eugene Jon Koay · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.